New public-private consortium will tackle gene therapies for rare diseases
Regulatory NewsKari Oakes
Biologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPreclinical studyRegulatory Intelligence/PolicyRegulatory NewsKari OakesBiologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPreclinical studyRegulatory Intelligence/Policy